Latest Industry Insights
Shark-Sourced Vaccine Ingredient May Be on Its Way Out
Shark-derived squalene is a common adjuvant product found in several approved vaccines. As calls for a sustainable source of squalene increase, researchers are exploring how yeast can be used to produce squalene analogues.
The UK Is Facing a Science and Tech Exodus
In this opinion piece, Liz Sparrow discusses the real risk of the UK losing its science and technology communities as they face a series of challenges that are threatening their growth.
An Authentic Approach to Food Safety
Dr. Mary McBride and Professor Chris Elliott, world-renowned for his work in food safety and authenticity, discuss his career to date, his passion for food safety, the projects his team are working on and the future.
High-Precision T-Cell Testing: Driving Diagnostics Forward
To learn more about T-cell testing, the types of diseases it can help to diagnose and its value in clinical trials, we spoke to Phill Keefe, chief executive officer of PerkinElmer’s Oxford Immunotec division.
Streamlining Lead Identification
To learn more about the Pioneer Antibody Discovery Platform and its potential impact on drug discovery and development, we spoke to Dr. John Cardone.
Leading by Example, Challenging the Sustainability Mindset
We spoke to Darlene Solomon to learn more about improving sustainability in science and Agilent’s commitment to My Green Lab and other sustainability initiatives.
Advances and New Technologies in Syndromic Testing
Technology Networks spoke with Arvind Kothandaraman to find out about the technologies underpinning syndromic testing, recent advances in the field and its possible role in pandemic prevention.
Using Data Lineage and Traceability to Optimize Publishing Potential
This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.
How CRISPR Is Transforming High-Throughput Screening
This article walks through the fundamentals of CRISPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.
Quality Control Automation for In Vitro Transcribed RNA
Technology Networks connected with Dr. Kyle Luttgeharm, product manager at Agilent, head of his talk for the Technology Networks online symposium: Vaccine Research and Development 2022.